Author

Sandy Haidar Ahmad

Université Bourgogne Franche-ComtéORCID 0000-0001-5375-0874Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Antoine Dutilleul· 1 shared Carine M. Van LintiD· 1 shared Estelle PlantiD· 1 shared Fabien PicaudiD· 1 shared Georges HerbeiniD· 1 shared Guillaume HerlemiD· 1 shared Mathilde GalaisiD· 1 shared Maxime BellefroidiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Antoine Dutilleul

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Highly potent antiviral drug candidates targeting SARS-CoV-2 nsp3 and nsp5

Mathilde Galais, Guillaume Herlem, Sandy Haidar Ahmad, Antoine Dutilleul, Sébastien Pasquereau, Ranim El Baba, Maxime Bellefroid, Estelle Plant, Stéphanie Morot-Bizot, Fabien Picaud, Georges Herbein, Carine M. Van Lint

The paper identifies two small molecules, Amb929 and Amb701, as potent inhibitors of SARS-CoV-2 nsp3 and nsp5, with Amb929 showing higher antiviral activity and lower cytotoxicity.

Biomedicine & Pharmacotherapy · Aug 4, 2026Peer-reviewedMicrobiology